Costing implications of recent treatment interruption studies

AIDS. 2006 Nov 14;20(17):2239-40. doi: 10.1097/01.aids.0000252057.02187.73.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiretroviral Therapy, Highly Active / economics*
  • CD4 Lymphocyte Count
  • Costs and Cost Analysis
  • Disease Progression
  • HIV Infections / drug therapy
  • HIV Infections / economics*
  • Humans
  • Withholding Treatment / economics